32nd Annual Meeting of the European Society for Hyperthermic Oncology

16–19 May 2018 • Berlin/Germany

32nd Annual Meeting of the European Society for Hyperthermic Oncology

16–19 May 2018 • Berlin/Germany

Kongressdetails

Abstract submission

Print-File

Industrial symposia

Budaörs/HU

The mission of the company was determined at its foundation in 1988 by the founder and inventor, Prof. Dr. András Szász.
Oncothermia (www.oncotherm.com) has become one of the leading Hyperthermia therapies in Europe. More than 200.000 Oncothermia treatments are performed every year. The therapy is used for patients with different tumour diseases in 5 continents in more than 30 countries.
The most key point in the company’s philosophy is the well-being of the patient, close to the Hippocratic principle: “Nil Nocere” (no harm). When developing the devices, we take the highest care in minimizing risks and using advantages because the treatment shall be both effective and comfortable for the patient. The company and its method cannot promise any miracles, but we guarantee the use of the latest technical and scientific standards.
Our mission is to increase the survival time of cancer patients, to improve their quality of life causing the fewest possible suffer and side-effects. Our intention is to produce high quality level medical devices to meet the state-of-art of oncology and tumor-therapies. Our goal is to make Oncothermia accepted among medical professions. We want to be a developer and manufacturer of our medical devices producing excellent quality and to reach a position of a globally accepted and widely used method.
Our strict quality management (ISO 9001 and ISO 13485) is a stable foundation for our CE/MDD-approval and we are certified by TÜV SÜD Product Service GmbH regularly.